JC
JPMorgan Chase & Co disclosed a 5.2% stake in NBIX
JPMorgan Chase & Co reported owning 5.2% of Neurocrine Biosciences Inc (NBIX) (5,300,390 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13G